Skip to main content
Fig. 7 | Molecular Medicine

Fig. 7

From: Pan-cancer analysis reveals RIPK2 predicts prognosis and promotes immune therapy resistance via triggering cytotoxic T lymphocytes dysfunction

Fig. 7

Expression level of RIPK2 at the single-cell stage. A UMAP graphs showed cellular clusters and the expression level of RIPK2 in different cellular types of BLCA, SKCM, and KIRC. B Single-cell RIPK2 expression profile of different cellular types in BLCA, SKCM, and KIRC. C Comparison of single-cell RIPK2 expression profile of immunotherapy non-responder with responder

Back to article page

Molecular Medicine

ISSN: 1528-3658